Molecular Imaging of Newly Diagnosed Prostate Cancer

被引：4
|
作者：
Williams, Scott [1 ,2 ]
机构：
[1] Peter MacCallum Canc Ctr, Div Radiat Oncol, 305 Grattan St, Melbourne, Vic 3000, Australia
[2] Univ Melbourne, Div Radiat Oncol, Melbourne, Vic, Australia
来源：
CANCER JOURNAL | 2020年 / 26卷 / 01期
关键词：
Positron emission tomography; prostate cancer; prostate-specific membrane antigen; POSITRON-EMISSION-TOMOGRAPHY; MEMBRANE ANTIGEN-EXPRESSION; GA-68-PSMA PET/CT; C-11-CHOLINE PET/CT; METASTASES; CARCINOMA; ACID; VALIDATION; RECURRENCE; ACCURACY;
D O I：
10.1097/PPO.0000000000000427
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Positron emission tomography (PET) is a valuable imaging in evaluating many malignancies. There are various molecular imaging tracers that are currently being utilized with prostate cancer (PC). Several PET agents imaging different molecular processes in PC have reached the clinic. While all of these agents have demonstrated an advantage over conventional imaging, there are considerable differences in the performance of each in staging newly diagnosed PC. In this article, we review the current updates available of different PET tracers, with a strong focus on the emerging role of prostate-specific membrane antigen PET in the management of newly diagnosed PC.
引用
收藏
页码：43 / 47
页数：5
相关论文
共 50 条
  • [1] INAPPROPRIATE UTILIZATION OF RADIOGRAPHIC IMAGING IN MEN WITH NEWLY DIAGNOSED PROSTATE CANCER
    Prasad, Sandip
    Gu, Xiangmei
    Hu, Jim
    JOURNAL OF UROLOGY, 2011, 185 (04): : E176 - E176
  • [2] Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer
    Prasad, S. M.
    Gu, X.
    Lipsitz, S. R.
    Nguyen, P. L.
    Hu, J. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [3] Impact of choosing wisely on imaging in men with newly diagnosed prostate cancer
    Lange, Suzanne M.
    Choudry, Mouneeb M.
    Hunt, Trevor C.
    Ambrose, Jacob P.
    Haaland, Benjamin A.
    Lowrance, William T.
    Hanson, Heidi A.
    O'Neil, Brock B.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (01) : 48.e19 - 48.e26
  • [4] Prostate radiotherapy in newly diagnosed metastatic prostate cancer
    Ali, Adnan
    Parker, Christopher C.
    Clarke, Noel W.
    CURRENT OPINION IN UROLOGY, 2019, 29 (06) : 620 - 628
  • [5] Clinical utility of molecular imaging in newly diagnosed metastatic breast cancer
    Schroder, Carolina Pia
    van Geel, Jasper
    Eisses, Bertha
    Elias, Sjoerd G.
    Brouwers, Adrienne H.
    Bensch, Frederike
    Gerritse, Sophie
    Angus, Lindsay
    Glaudemans, Andor W. J. M.
    Kuip, Evelien J. M.
    Jager, Agnes
    Oprea-Lager, Daniela E.
    Vugts, Danielle J.
    Emmering, Jasper
    Arens, Anne I. J.
    Oyen, Wim J. G.
    van der Vegt, Bert
    Lub-de Hooge, Marjolijn N.
    Menke, Catharina Wilhelmina
    De Vries, Elisabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] MOLECULAR CLASSIFIER TESTING FOR NEWLY DIAGNOSED LOCALIZED PROSTATE CANCER IN THE STATE OF MICHIGAN
    Hu, Jonathan
    Spratt, Daniel
    Tosoian, Jeffrey
    Qi, Ji
    Kaye, Deborah
    Johnson, Anna
    Linsell, Susan
    Montie, James
    Ghani, Khurshid
    Miller, David
    Wojno, Kirk
    Burks, Frank
    Morgan, Todd
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1064 - E1065
  • [7] Empowerment of men newly diagnosed with prostate cancer
    Davison, BJ
    Degner, LF
    CANCER NURSING, 1997, 20 (03) : 187 - 196
  • [8] Psychosocial adjustment in newly diagnosed prostate cancer
    Love, Anthony W.
    Scealy, Marita
    Bloch, Sidney
    Duchesne, Gill
    Couper, Jeremy
    Macvean, Michelle
    Costello, Anthony
    Kissane, David W.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2008, 42 (05): : 423 - 429
  • [9] Radiotherapy for newly diagnosed oligometastatic prostate cancer
    Boeri, Luca
    Sharma, Vidit
    Karnes, R. Jeffrey
    LANCET, 2018, 392 (10162): : 2327 - 2328
  • [10] Counseling patients with newly diagnosed prostate cancer
    Thompson, IM
    ONCOLOGY-NEW YORK, 2000, 14 (01): : 119 - +
12345